3847-58-3O=[N+]([O-])c1ccc(F)c(Cl)c1FCTVBVNKEMCGZDF-UHFFFAOYSA-N3847-58-3DTXSID50278833Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H302: Harmful if swallowed [Warning Acute toxicity, oral]
P260, P261, P264, P270, P272, P273, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P330, P333+P317, P362+P364, P363, P391, P405, and P501 (click each P-code to see the statement)
Danger
H301 (12.5%): Toxic if swallowed [Danger Acute toxicity, oral]
P260, P261, P262, P264, P264+P265, P270, P271, P272, P273, P280, P301+P316, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P319, P321, P330, P332+P317, P333+P317, P337+P317, P361+P364, P362+P364, P363, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Acute Tox. 4 (100%)
Acute Tox. 3 (12.5%)
Acute toxicity - category 4
Acute Tox. 4 *
Verwenden3-Chloro-2,4-difluoronitrobenzene is a pharmaceutical intermediate, which is reported in the literature to be used for the preparation of LSD1 inhibitors and selective HER2 inhibitors.
Wird geladen…